CinCor is a clinical-stage cardiorenal therapeutics company with a novel clinical-stage candidate, CIN-107 that has the potential to dramatically expand therapeutic options for patients suffering from hypertension and its associated risks.

Biotechnology

CinCor Pharma

Marc De Garidel

Michael Kalb

William (Bill) Marshall

Kevin Schutz, PharmD

William Marshall

Kevin Schutz

Jack Greene

James Hui

Jane Chamberland

Catherine Pearce

Jonathan Isaacsohn

The Scientific Team at CinCor Pharma is responsible for guiding the development and clinical trials of CIN-107, leveraging their expertise to optimize therapeutic strategies, analyze clinical data, and ensure the efficacy and safety of the drug in treating hypertension and related cardiorenal conditions. This team of scientific advisors works collaboratively to advance the company's innovative treatment options.

Scientific Team

Clinical and Medical Team

Leadership Team

Scientific Team

About

Team members

Other teams at CinCor Pharma

Clinical and Medical Team

Leadership Team